Meningococcal C conjugate vaccination campaign: the Dutch experience
Timen, A.; Neppelenbroek, S.; de Vries, M.; de Greeff, S. · Das Gesundheitswesen · 2004 · Heft 4 · S. 1 bis 1
Bibliografische Angaben
Zusammenfassung
In 2001 The Netherlands experienced an increase in notifications of group C meningococcal disease. By the end of 2001 serogroup C caused 38% of all meningococcal infections (incidence of 1,7/100.000), while in previous years about 14–20% of all meningococci belonged to serogroup C. During the first 3 months of 2002, serogroup C was found in 45% of the cases (data from The Netherlands Reference Laboratory for Bacterial Meningitis). In August 2001 a cluster of menC requested immunization of 5000 children with conjugated vaccine. The increase in menC and the occurrence of clusters prompted the Ministry of Health (M…